Answers are grounded in this paper and cite their sources.
Tadalafil (TD) is a phosphodiesterase type 5 (PDE-5) inhibitor that has gained attention for its wound healing properties. In this study, a TD-loaded hydrogel was prepared and characterized, and its wound-healing efficacy was evaluated. After preparing the TD hydrogel, its physicochemical properties such as viscosity, pH, drug-loading capacity (DL%), in vitro release behavior, and stability were characterized. Moreover, in vivo studies were performed to evaluate hydroxyproline (HP) and the wound healing efficacy of 1, 1.5, 3% (w/w) TD hydrogels in New Zealand rabbits. Histopathological analysis was also performed using hematoxylin and eosin (H&E) staining. We successfully prepared a TD hydrogel with high stability. The results of the in vivo experiments on full-thickness wounds showed that the 1.5% TD hydrogel with a pH of 5.81 ± 0.421, viscosity of 12,435 ± 63, drug-loading capacity of 91.73 ± 1.482%, and drug release rate of 88% was superior to other formulations when HP level was increased, which decreased the time required for wound healing; this was corroborated by the histological analysis. Thus, the TD hydrogel formulation prepared in this study is a promising topical therapeutic agent for wound healing. • Tadalafil-loaded hydrogel was prepared, and characterized. • The wound healing efficacy of Tadalafil hydrogel was evaluated. • The 1.5% Tadalafil hydrogel was superior to other formulations. • The 1.5% Tadalafil hydrogel increased the hydroxyproline level and decreased the time needed for wound healing.
No takes yet. Share an insight, caveat, or question.
Pajouhi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: